(Q38463027)

English

The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives

scientific article published on 14 February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jacqueline M Dekker

4

object named as

J M Dekker

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Eleuterio Ferrannini

8

object named as

E Ferrannini

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

S A Hills

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

B Balkau

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

S W Coppack

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Mari

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

M Walker

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Report prepared on behalf of the EGIR-RISC Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

566-570

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

https://scigraph.springernature.com/pub.10.1007/s00125-004-1335-5

0 references

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Prospective analysis of the insulin-resistance syndrome (syndrome X).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

How good a marker is insulin level for insulin resistance?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Insulin: in search of a syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Insulin action and age. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Branched equation modeling of simultaneous accelerometry and heart rate monitoring improves estimate of directly measured physical activity energy expenditure

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

International physical activity questionnaire: 12-country reliability and validity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

In vivo ultrasonic parametric imaging of carotid atherosclerotic plaque by videodensitometric technique.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Insulin action and non-esterified fatty acids

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1335-5

21 January 2018

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/14968294

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-004-1335-5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38463027&oldid=1760912925"